NOS1 and neoplasm: The results of this experiment confirmed the ability of T1084 to have a pronounced and stable antitumor effect against CC-5 and the absence of the significant adaptation of neoplasia to NOS/PDK inhibitor subchronic exposure (Figure 3B,D).